X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12-16 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $7.88 | -6,442 | 98,702 | -6% | -$50,794 | ||||||
2024-12-06 | HCAT | Alger Jason | CFO | S - Sale | $8.32 | -19,599 | 86,712 | -18% | -$163,050 | ||||||
2024-12-06 | HCAT | Landry Benjamin | GC | S - Sale | $8.32 | -19,268 | 72,250 | -21% | -$160,294 | ||||||
2024-12-04 | HCAT | Lesueur Daniel | COO | S - Sale | $7.70 | -22,773 | 96,462 | -19% | -$175,243 | ||||||
2024-12-02 | HCAT | Freeman Kevin Lee | Chief Commercial Officer | S - Sale | $8.94 | -7,500 | 236,950 | -3% | -$67,073 | ||||||
2024-11-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $8.50 | -1,365 | 112,910 | -1% | -$11,603 | ||||||
2024-11-05 | HCAT | Lesueur Daniel | COO | S - Sale | $7.70 | -5,209 | 129,690 | -4% | -$40,127 | ||||||
2024-10-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $8.16 | -1,324 | 114,275 | -1% | -$10,804 | ||||||
2024-10-03 | HCAT | Lesueur Daniel | COO | S - Sale | $7.68 | -5,209 | 134,899 | -4% | -$40,011 | ||||||
2024-09-16 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $8.43 | -1,324 | 115,599 | -1% | -$11,161 | ||||||
2024-09-06 | HCAT | Landry Benjamin | GC | S - Sale | $7.39 | -2,466 | 100,937 | -2% | -$18,222 | ||||||
2024-09-06 | HCAT | Alger Jason | CFO | S - Sale | $7.39 | -2,899 | 114,106 | -2% | -$21,427 | ||||||
2024-09-04 | HCAT | Lesueur Daniel | COO | S - Sale | $7.58 | -8,137 | 140,108 | -5% | -$61,718 | ||||||
2024-09-03 | HCAT | Freeman Kevin Lee | Chief Commercial Officer | S - Sale | $7.22 | -7,500 | 255,881 | -3% | -$54,174 | ||||||
2024-08-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $6.57 | -1,328 | 118,536 | -1% | -$8,725 | ||||||
2024-08-05 | HCAT | Lesueur Daniel | COO | S - Sale | $6.19 | -5,209 | 150,006 | -3% | -$32,224 | ||||||
2024-07-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $6.51 | -1,290 | 119,864 | -1% | -$8,398 | ||||||
2024-07-03 | HCAT | Lesueur Daniel | COO | S - Sale | $6.15 | -5,208 | 155,215 | -3% | -$32,049 | ||||||
2024-06-17 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $6.37 | -1,290 | 121,154 | -1% | -$8,221 | ||||||
2024-06-12 | HCAT | Alger Jason | CFO | S - Sale | $6.83 | -2,823 | 118,170 | -2% | -$19,281 | ||||||
2024-06-06 | HCAT | Landry Benjamin | GC | S - Sale | $6.71 | -2,387 | 104,625 | -2% | -$16,018 | ||||||
2024-06-06 | HCAT | Lesueur Daniel | COO | S - Sale | $6.72 | -11,923 | 160,423 | -7% | -$80,064 | ||||||
2024-06-11 | HCAT | Freeman Kevin Lee | Chief Commercial Officer | S - Sale | $6.53 | -7,500 | 266,153 | -3% | -$49,008 | ||||||
2024-05-31 | HCAT | Landry Benjamin | GC | S - Sale | $6.61 | -12,577 | 107,012 | -11% | -$83,133 | ||||||
2024-05-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $7.00 | -2,066 | 124,160 | -2% | -$14,462 | ||||||
2024-04-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $6.11 | -2,005 | 126,226 | -2% | -$12,251 | ||||||
2024-03-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $7.80 | -2,005 | 128,231 | -2% | -$15,648 | ||||||
2024-02-27 | HCAT | Burton Daniel D. | CEO | P - Purchase | $7.81 | +26,200 | 1,172,623 | +2% | +$204,525 | ||||||
2024-02-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $9.77 | -3,262 | 64,786 | -5% | -$31,855 | ||||||
2024-01-16 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $10.83 | -3,163 | 68,048 | -4% | -$34,246 | ||||||
2023-12-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $8.83 | -3,163 | 71,211 | -4% | -$27,923 | ||||||
2023-12-06 | HCAT | Alger Jason | Chief Accounting Officer | S - Sale | $7.55 | -2,177 | 51,927 | -4% | -$16,436 | ||||||
2023-11-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $8.25 | -1,196 | 78,535 | -2% | -$9,867 | ||||||
2023-10-16 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $8.33 | -1,161 | 79,731 | -1% | -$9,671 | ||||||
2023-09-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $11.01 | -1,160 | 80,892 | -1% | -$12,772 | ||||||
2023-09-06 | HCAT | Landry Benjamin | GC | S - Sale | $11.52 | -1,157 | 28,187 | -4% | -$13,332 | ||||||
2023-09-06 | HCAT | Alger Jason | Chief Accounting Officer | S - Sale | $11.65 | -2,197 | 56,942 | -4% | -$25,597 | ||||||
2023-08-22 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $11.90 | -737 | 83,536 | -1% | -$8,770 | ||||||
2023-07-07 | HCAT | Landry Benjamin | GC | S - Sale | $11.14 | -1,179 | 29,844 | -4% | -$13,134 | ||||||
2023-06-06 | HCAT | Alger Jason | Chief Accounting Officer | S - Sale | $11.84 | -2,370 | 60,068 | -4% | -$28,061 | ||||||
2023-06-06 | HCAT | Landry Benjamin | GC | S - Sale | $11.84 | -1,078 | 29,844 | -3% | -$12,764 | ||||||
2023-06-05 | HCAT | Hunt Bryan Truman | CFO | S - Sale | $12.00 | -650 | 238,668 | 0% | -$7,800 | ||||||
2023-05-12 | HCAT | Burton Daniel D. | CEO | P - Purchase | $10.19 | +49,050 | 919,415 | +6% | +$499,594 | ||||||
2023-03-03 | HCAT | Alger Jason | Chief Accounting Officer | S - Sale | $14.23 | -2,967 | 55,323 | -5% | -$42,229 | ||||||
2023-03-03 | HCAT | Hunt Bryan Truman | CFO | S - Sale | $14.34 | -760 | 232,826 | 0% | -$10,898 | ||||||
2023-02-15 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $13.82 | -662 | 49,045 | -1% | -$9,149 | ||||||
2023-01-17 | HCAT | Llewelyn Linda | Chief People Officer | S - Sale | $12.12 | -642 | 49,707 | -1% | -$7,781 | ||||||
| M | 2023-01-17 | HCAT | Hunt Bryan Truman | CFO | S - Sale | $12.28 | -4,409 | 136,937 | -3% | -$54,163 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |